FOSL1 and breast carcinoma: Thus, we determined whether other lung as well as breast cancer cell lines that express high levels of FRA1 and/or PARP7 also exhibited increased RBN-2397 sensitivity compared to cell lines with lower FRA1 and/or PARP7 expression levels (Fig. 6A and SI Appendix, Fig. S6D).